Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma

HepaCAM induces G1 phase arrest and promotes c-Myc degradation in human renal cell carcinoma

(2011) Qiao-Lin Zhang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Tumor Biology and Prognostic Factors in Renal Cell Carcinoma

(2011) D. S. Finley et al.   ONCOLOGIST

Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma

(2010) Jeffrey La Rochelle et al.   CANCER

Molecular Signatures of Localized Clear Cell Renal Cell Carcinoma to Predict Disease-Free Survival after Nephrectomy

(2009) T. Klatte et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney

(2009) R. Beroukhim et al.   CANCER RESEARCH

Chromosome 8p Deletions and 8q Gains are Associated with Tumor Progression and Poor Prognosis in Prostate Cancer

(2009) A. T. El Gammal et al.   CLINICAL CANCER RESEARCH

Cytogenetic and Molecular Tumor Profiling for Type 1 and Type 2 Papillary Renal Cell Carcinoma

(2009) T. Klatte et al.   CLINICAL CANCER RESEARCH

Cytogenetic Profile Predicts Prognosis of Patients With Clear Cell Renal Cell Carcinoma

(2009) Tobias Klatte et al.   JOURNAL OF CLINICAL ONCOLOGY

HIF-α Effects on c-Myc Distinguish Two Subtypes of Sporadic VHL-Deficient Clear Cell Renal Carcinoma

(2008) John D. Gordan et al.   CANCER CELL

MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells

(2008) Sai-Wen Tang et al.   CANCER LETTERS

Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma

(2008) Jean-Jacques Patard et al.   INTERNATIONAL JOURNAL OF CANCER

Molecular Biology of Renal Cortical Tumors

(2008) Tobias Klatte et al.   UROLOGIC CLINICS OF NORTH AMERICA